MedTrace Logo

Resistant Maltodextrin Supplementation: Gastrointestinal Health

NCT02733263 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 64

Last updated 2018-03-02

No results posted yet for this study

Summary

Resistant maltodextrin (RMD) is an indigestible water soluble fiber that increases fecal bulk by enhancing growth of specific microbial populations; however the effect of RMD on bifidobacteria and total fecal weight is not clear. The purpose of this research study is to determine whether incorporating about ¼ cup of a fiber supplement into the diet will induce beneficial changes in gastrointestinal function, the fecal microbiota profile (increased number of healthy bacteria in stool) and immune processes resulting in improved quality of life.

Conditions

  • Healthy

Interventions

DIETARY_SUPPLEMENT

15 g RMD

15 grams of resistant maltodextrin

DIETARY_SUPPLEMENT

25 g RMD

25 grams of resistant maltodextrin

DIETARY_SUPPLEMENT

0 g RMD

0 grams of resistant maltodextrin

Sponsors & Collaborators

  • ADM/Matsutani LLC

    collaborator UNKNOWN

  • University of Florida

    lead OTHER

Principal Investigators

  • Bobbi Langkamp-Henken, PhD · University of Florida

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
TRIPLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-05-31
Primary Completion
2016-06-30
Completion
2016-11-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02733263 on ClinicalTrials.gov